Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sarepta Therapeutics Inc (NASDAQ:SRPT)

26.09
BATS BZX Real-Time Price
As of 12:17pm ET
 -1.12 / -4.12%
Today’s Change
8.00
Today|||52-Week Range
41.97
-32.37%
Year-to-Date
Mallinckrodt DMD Drug Gets Fast Track Status in the U.S.
Aug 26 / Zacks.com - Paid Partner Content
3 Biotech Stocks With Explosive Upside Potential
Aug 23 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close27.21
Today’s open27.21
Day’s range26.06 - 27.31
Volume55,291
Average volume (3 months)5,377,150
Market cap$1.3B
Dividend yield--
Data as of 12:17pm ET, 08/31/2016

Growth & Valuation

Earnings growth (last year)-53.39%
Earnings growth (this year)+1.43%
Earnings growth (next 5 years)+0.37%
Revenue growth (last year)-87.16%
P/E ratioNM
Price/Sales1,302.11
Price/Book6.52

Competitors

 Today’s
change
Today’s
% change
TXMDTherapeuticsMD Inc-0.15-2.18%
TBPHTheravance Biopharma...-0.60-2.11%
DEPODepomed Inc-0.03-0.15%
LCILannett Company Inc-0.54-1.62%
Data as of 12:18pm ET, 08/31/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$1.28
Annual revenue (last year)$1.3M
Annual profit (last year)-$220.0M
Net profit margin-17,560.26%

Profile

Sector
Health Technology
Industry
Biotechnology
Senior VP, Chief Executive &
Medical Officer
Edward M. Kaye
Head-Operations &
Vice President
Gavin T. Malenfant
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Search for Jobs